Actinium Pharmaceuticals
ATNM
ATNM
59 hedge funds and large institutions have $46.1M invested in Actinium Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 7 closing their positions.
Holders
59
Holders Change
+4
Holders Change %
+7.27%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
25
Reduced
9
Closed
7
Calls
$3.46M
Puts
$4.18M
Net Calls
-$712K
Net Calls Change
-$1.93M
Top Buyers
| 1 |
1
D.E. Shaw & Co
New York
|
$2.95M |
| 2 |
2
BlackRock
New York
|
$5.14M |
| 3 |
3
Two Sigma Investments
New York
|
$2.27M |
| 4 |
EI
4
EAM Investors
Solana Beach,
California
|
$2.1M |
| 5 |
5
Two Sigma Advisers
New York
|
$2.55M |
